HLF and PPARα axis regulates metabolic-associated fatty liver disease through extracellular vesicles derived from the intestinal microbiota

Abstract

Metabolic-associated fatty liver disease (MAFLD) has become increasingly widespread. The intestine is the primary site of lipid absorption and is important for the homeostasis of lipid metabolism. However, the mechanism underlying the participation of the intestinal tract in the development of MAFLD requires additional investigation. In this study, analysis of the single-cell transcriptome of intestinal tissue from cynomolgus monkeys found that hepatic leukemia factor (HLF) participated in the genetic regulation of intestinal lipid absorption. Results obtained from normal and intestine-specific Hlf-knockout mice confirmed that HLF alleviated intestinal barrier disorders by inhibiting peroxisome proliferator-activated receptor alpha (PPARα) expression. The HLF/PPARα axis alleviated MAFLD by mediating gut microbiota-derived extracellular vesicles (fEVs), thereby inhibiting hepatocyte ferroptosis. Lipidomics and functional experiments verified that taurochenodeoxycholic acid (TCDCA), a conjugated bile acid contained in the fEVs, had a key role in the process. In conclusion, intestinal HLF activity was mediated by fEVs and identified as a novel therapeutic target for MAFLD.

Keywords

bile acids / extracellular vesicles / ferroptosis / gut microbiome / HLF / MAFLD

References

[1] Pipitone, Rosaria Maria, Carlo Ciccioli, Giuseppe Infantino, Claudia La Mantia, Stefanie Parisi, Adele Tulone, Grazia Pennisi, Stefania Grimaudo, and Salvatore Petta. 2023. “MAFLD: A Multisystem Disease.” Therapeutic Advances in Endocrinology and Metabolism 14: 20420188221145549. https://doi.org/10.1177/20420188221145549

[2] Loomba, Rohit, and Arun J. Sanyal. 2013. “The Global NAFLD Epidemic.” Nature Reviews Gastroenterology & Hepatology 10: 686-690. https://doi.org/10.1038/nrgastro.2013.171

[3] Kaya, Eda, and Yusuf Yilmaz. 2019. “Non-Alcoholic Fatty Liver Disease: A Growing Public Health Problem in Turkey.” The Turkish Journal of Gastroenterology 30: 865-871. https://doi.org/10.5152/tjg.2019.18045

[4] Marshall, John C. 1998. “The Gut as a Potential Trigger of Exercise-Induced Inflammatory Responses.” Canadian Journal of Physiology and Pharmacology 76: 479-484. https://doi.org/10.1139/y98-049

[5] Tripathi, Anupriya, Justine Debelius, David A. Brenner, Michael Karin, Rohit Loomba, Bernd Schnabl, and Rob Knight. 2018. “The Gut-Liver Axis and the Intersection with the Microbiome.” Nature Reviews Gastroenterology & Hepatology 15: 397-411. https://doi.org/10.1038/s41575-018-0011-z

[6] Thompson, Mikayla R., John J. Kaminski, Evelyn A. Kurt Jones, and Katherine A. Fitzgerald. 2011. “Pattern Recognition Receptors and the Innate Immune Response to Viral Infection.” Viruses 3: 920-940. https://doi.org/10.3390/v3060920

[7] Ren, Zhihua, Chaoyue Guo, Shumin Yu, Ling Zhu, Ya Wang, Hui Hu, and Junliang Deng. 2019. “Progress in Mycotoxins Affecting Intestinal Mucosal Barrier Function.” International Journal of Molecular Sciences 20: 2777. https://doi.org/10.3390/ijms20112777

[8] Perez-Lopez, Araceli, Judith Behnsen, Sean Paul Nuccio, and Manuela Raffatellu. 2016. “Mucosal Immunity to Pathogenic Intestinal Bacteria.” Nature Reviews Immunology 16: 135-148. https://doi.org/10.1038/nri.2015.17

[9] Jovel, Juan, Levinus A. Dieleman, Dina Kao, Andrew L. Mason, and Eytan Wine. 2018. “The Human Gut Microbiome in Health and Disease.” In Metagenomics, edited by Nagarajan Muniyandi, (Academic Press) 197-213. https://doi.org/10.1016/B978-0-08-102268-9.00010-0

[10] Clemente, Jose C., Luke K. Ursell, Laura Wegener Parfrey, and Rob Knight. 2012. “The Impact of the Gut Microbiota on Human Health: An Integrative View.” Cell 148: 1258-1270. https://doi.org/10.1016/j.cell.2012.01.035

[11] Hosseini-Giv, Niloufar, Alyza Basas, Chloe Hicks, Emad El Omar, Fatima El Assaad, and Elham Hosseini Beheshti. 2022. “Bacterial Extracellular Vesicles and Their Novel Therapeutic Applications in Health and Cancer.” Frontiers in Cellular and Infection Microbiology 12: 962216. https://doi.org/10.3389/fcimb.2022.962216

[12] Jahromi, Leila Pourtalebi, and Gregor Fuhrmann. 2021. “Bacterial Extracellular Vesicles: Understanding Biology Promotes Applications as Nanopharmaceuticals.” Advanced Drug Delivery Reviews 173: 125-140. https://doi.org/10.1016/j.addr.2021.03.012

[13] Ellis, Terri N., and Meta J. Kuehn. 2010. “Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles.” Microbiology and Molecular Biology Reviews 74: 81-94. https://doi.org/10.1128/mmbr.00031-09

[14] Villard, Alexandre, Jérôme Boursier, and Ramaroson Andriantsitohaina. 2021. “Bacterial and Eukaryotic Extracellular Vesicles and Nonalcoholic Fatty Liver Disease: New Players in the Gut-Liver Axis?” American Journal of Physiology-Gastrointestinal and Liver Physiology 320: G485-G495. https://doi.org/10.1152/ajpgi.00362.2020

[15] Gachon, Frédéric, Philippe Fonjallaz, Francesca Damiola, Pascal Gos, Tohru Kodama, Jozsef Zakany, Denis Duboule, et al. 2004. “The Loss of Circadian PAR bZip Transcription Factors Results in Epilepsy.” Genes & Development 18: 1397-1412. https://doi.org/10.1101/gad.301404

[16] Wang, Qing, Marc Maillard, Ueli Schibler, Michel Burnier, and Frédéric Gachon. 2010. “Cardiac Hypertrophy, Low Blood Pressure, and Low Aldosterone Levels in Mice Devoid of the Three Circadian PAR bZip Transcription Factors DBP, HLF, and TEF.” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 299: R1013-R1019. https://doi.org/10.1152/ajpregu.00241.2010

[17] Gachon, Frédéric, Fabienne Fleury Olela, Olivier Schaad, Patrick Descombes, and Ueli Schibler. 2006. “The Circadian PAR-domain Basic Leucine Zipper Transcription Factors DBP, TEF, and HLF Modulate Basal and Inducible Xenobiotic Detoxification.” Cell Metabolism 4: 25-36. https://doi.org/10.1016/j.cmet.2006.04.015

[18] Xiang, Dai-Min, Wen Sun, Beifang Ning, Tengfei Zhou, Xiaofeng Li, Wei Zhong, Zhuo Cheng, et al. 2018. “The HLF/IL-6/STAT3 Feedforward Circuit Drives Hepatic Stellate Cell Activation to Promote Liver Fibrosis.” Gut 67: 1704-1715. https://doi.org/10.1136/gutjnl-2016-313392

[19] Xiang, Dai-Min, Wen Sun, Tengfei Zhou, Cheng Zhang, Zhuo Cheng, Shichao Li, Weiqi Jiang, et al. 2019. “Oncofetal HLF Transactivates C-Jun to Promote Hepatocellular Carcinoma Development and Sorafenib Resistance.” Gut 68: 1858-1871. https://doi.org/10.1136/gutjnl-2018-317440

[20] Dzitoyeva, Svetlana, and Hari Manev. 2013. “Reduction of Cellular Lipid Content by a Knockdown of Drosophila PDP1γ and Mammalian Hepatic Leukemia Factor.” Journal of Lipids 2013: 297932. https://doi.org/10.1155/2013/297932

[21] Zhang, Xianglong, Liangbiao George Hu, Ying Lei, Marina Stolina, Oliver Homann, Songli Wang, Murielle M. Véniant, and Yi Hsiang Hsu. 2023. “A Transcriptomic and Proteomic Atlas of Obesity and Type 2 Diabetes in Cynomolgus Monkeys.” Cell Reports 42: 112952. https://doi.org/10.1016/j.celrep.2023.112952

[22] Stojanov, Spase, Aleš Berlec, and Borut Štrukelj. 2020. “The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel Disease.” Microorganisms 8: 1715. https://doi.org/10.3390/microorganisms8111715

[23] Reszka, Edyta, and Shanbeh Zienolddiny. 2018. “Epigenetic Basis of Circadian Rhythm Disruption in Cancer.” Cancer Epigenetics for Precision Medicine: Methods and Protocols 1856: 173-201. https://doi.org/10.1007/978-1-4939-8751-1_18

[24] Ahmadi, Mohsen, Amirhossein Mohajeri Khorasani, Firouzeh Morshedzadeh, Negin Saffarzadeh, Sayyed Mohammad Hossein Ghaderian, Soudeh Ghafouri Fard, and Pegah Mousavi. 2024. “HLF Is a Promising Prognostic, Immunological, and Therapeutic Biomarker in Human Tumors.” Biochemistry and Biophysics Reports 38: 101725. https://doi.org/10.1016/j.bbrep.2024.101725

[25] Musso, Orlando, and Naiara Beraza. 2019. “Hepatocellular Carcinomas: Evolution to Sorafenib Resistance Through Hepatic Leukaemia Factor.” Gut 68: 1728-1730. https://doi.org/10.1136/gutjnl-2019-318999

[26] Li, Hengyu, Pinghua Yang, Jinghan Wang, Jin Zhang, Qianyun Ma, Yingjie Jiang, Yani Wu, Tao Han, and Daimin Xiang. 2022. “HLF Regulates Ferroptosis, Development and Chemoresistance of Triple-Negative Breast Cancer by Activating Tumor Cell-Macrophage Crosstalk.” Journal of Hematology & Oncology 15: 2. https://doi.org/10.1186/s13045-021-01223-x

[27] Flowers, Matthew T., Mark P. Keller, YounJeong Choi, Hong Lan, Christina Kendziorski, James M. Ntambi, and Alan D. Attie. 2008. “Liver Gene Expression Analysis Reveals Endoplasmic Reticulum Stress and Metabolic Dysfunction in SCD1-Deficient Mice Fed a Very Low-Fat Diet.” Physiological Genomics 33: 361-372. https://doi.org/10.1152/physiolgenomics.00139.2007

[28] Shen, Yue, Maria Letizia Giardino Torchia, Gregory W. Lawson, Christopher L. Karp, Jonathan D. Ashwell, and Sarkis K. Mazmanian. 2012. “Outer Membrane Vesicles of a Human Commensal Mediate Immune Regulation and Disease Protection.” Cell Host & Microbe 12: 509-520. https://doi.org/10.1016/j.chom.2012.08.004

[29] Fizanne, Lionel, Alexandre Villard, Nadia Benabbou, Sylvain Recoquillon, Raffaella Soleti, Erwan Delage, Mireille Wertheimer, et al. 2023. “Faeces-Derived Extracellular Vesicles Participate in the Onset of Barrier Dysfunction Leading to Liver Diseases.” Journal of Extracellular Vesicles 12: 12303. https://doi.org/10.1002/jev2.12303

[30] Choi, Youngwoo, Yonghoon Kwon, Dae Kyum Kim, Jinseong Jeon, Su Chul Jang, Taejun Wang, Minjee Ban, et al. 2015. “Gut Microbe-Derived Extracellular Vesicles Induce Insulin Resistance, Thereby Impairing Glucose Metabolism in Skeletal Muscle.” Scientific Reports 5: 15878. https://doi.org/10.1038/srep15878

[31] Chelakkot, Chaithanya, Youngwoo Choi, Dae Kyum Kim, Hyun T. Park, Jaewang Ghim, Yonghoon Kwon, and Jinseong Jeon, et al. 2018. “Akkermansia Muciniphila-Derived Extracellular Vesicles Influence Gut Permeability Through the Regulation of Tight Junctions.” Experimental & Molecular Medicine 50: e450. https://doi.org/10.1038/emm.2017.282

[32] Ridlon, Jason M., and H Rex Gaskins. 2024. “Another Renaissance for Bile Acid Gastrointestinal Microbiology.” Nature Reviews Gastroenterology & Hepatology 21: 348-364. https://doi.org/10.1038/s41575-024-00896-2

[33] Yokota, Atsushi, Satoru Fukiya, KBM Saiful Islam, Tadasuke Ooka, Yoshitoshi Ogura, Tetsuya Hayashi, Masahito Hagio, and Satoshi Ishizuka. 2012. “Is Bile Acid a Determinant of the Gut Microbiota on a High-Fat Diet?” Gut Microbes 3: 455-459. https://doi.org/10.4161/gmic.21216

[34] Kuang, Junliang, Jieyi Wang, Yitao Li, Mengci Li, Mingliang Zhao, Kun Ge, Dan Zheng, et al. 2023. “Hyodeoxycholic Acid Alleviates Non-Alcoholic Fatty Liver Disease Through Modulating the Gut-Liver Axis.” Cell Metabolism 35: 1752-1766.e8. https://doi.org/10.1016/j.cmet.2023.07.011

[35] Cui, Na, Wensen Zhang, Fazhi Su, Zhihong Zhang, Biao Li, Donghui Peng, Yanping Sun, et al. 2023. “Metabolomic and Lipidomic Studies on the Intervention of Taurochenodeoxycholic Acid in Mice With Hyperlipidemia.” Frontiers in Pharmacology 14: 1255931. https://doi.org/10.3389/fphar.2023.1255931

[36] Huang, Fengjie, Xiaojiao Zheng, Xiaohui Ma, Runqiu Jiang, Wangyi Zhou, Shuiping Zhou, Yunjing Zhang, et al. 2019. “Theabrownin from Pu-Erh Tea Attenuates Hypercholesterolemia via Modulation of Gut Microbiota and Bile Acid Metabolism.” Nature Communications 10: 4971. https://doi.org/10.1038/s41467-019-12896-x

[37] Gao, Hong, Zhongmou Jin, Gautam Bandyopadhyay, Gaowei Wang, Dinghong Zhang, Karina Cunha e Rocha, Xiao Liu, et al. 2022. “Aberrant Iron Distribution via Hepatocyte-Stellate Cell Axis Drives Liver Lipogenesis and Fibrosis.” Cell Metabolism 34: 1201-1213.e5. https://doi.org/10.1016/j.cmet.2022.07.006

[38] Barrera, Cynthia, Rodrigo Valenzuela, Miguel Ángel Rincón, Alejandra Espinosa, Francisca Echeverria, Nalda Romero, Daniel Gonzalez-Mañan, and Luis A. Videla. 2018. “Molecular Mechanisms Related to the Hepatoprotective Effects of Antioxidant-Rich Extra Virgin Olive Oil Supplementation in Rats Subjected to Short-Term Iron Administration.” Free Radical Biology and Medicine 126: 313-321. https://doi.org/10.1016/j.freeradbiomed.2018.08.030

[39] Lin, Feiyan, Wenyi Chen, Jiahang Zhou, Jiaqi Zhu, Qigu Yao, Bing Feng, Xudong Feng, et al. 2022. “Mesenchymal Stem Cells Protect Against Ferroptosis via Exosome-Mediated Stabilization of SLC7A11 in Acute Liver Injury.” Cell Death & Disease 13: 271. https://doi.org/10.1038/s41419-022-04708-w

[40] Caballano-Infantes, Estefanía, Ailec Ho Plágaro, Carlos López Gómez, Flores Martín Reyes, Francisca Rodríguez Pacheco, Bernard Taminiau, Georges Daube, et al. 2023. “Membrane Vesicles of Toxigenic Clostridioides Difficile Affect the Metabolism of Liver HepG2 Cells.” Antioxidants 12: 818. https://doi.org/10.3390/antiox12040818

RIGHTS & PERMISSIONS

2025 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.